Login

Journal Front Page

News & Events

  • Call for article for April 2024 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

FORMULATION AND EVALUATION OF GESTRORETENTIVE FLOATING TABLET OF PERINDOPRIL

Sanju Singh1, Abhishek Dwivedi1, Shubendu Mishra2, Avalani Gunjan3

1. Department of Pharmaceutics, RKDF University, Bhopal, M.P.
2. Department of Pharmaceutics, Radharaman College of Pharmacy, Bhopal, M.P.
3. Department of Quality, Bajaj Health Care, Baroda. Gujarat

ABSTRACT

Oral delivery of drugs is by far the most preferable route of drug delivery due to the ease of administration, patient compliance and flexibility in formulation etc. From immediate release to site specific delivery, oral dosage forms have really progressed. Gastro retentive dosage forms significantly extend the period of time, over which drug may be released and thus prolong dosing intervals and increase patient compliance. Perindopril Eribumineis an angiotensin converting enzyme inhibitor and is used in the treatment of hypertensive and congestive cardiac failure. The bioavailability of Perindopril following oral administration is very low. Perindopril is absorbed rapidly on oral administration. When administered orally, frequent dosing is needed due to its short biological half life (0.8-1hr).Secondly drug undergoes high hepatic first pass metabolism. The present study focus on the development of floating tablets of perindopril hydrochloride using different polymer grades to achieve a sustained release for 24 hrs.

Keywords: Gastro retention, Angiotensin System, Gastroretnial tract system


[Full Text Article]